Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma
Philipp K. Haber, Florian Castet, Miguel Torres‐Martín, Carmen Andreu-Oller, Marc Puigvehí, Maeda Miho, Pompilia Radu, Jean‐François Dufour, Chris Verslype, Carolin Zimpel, Jens U. Marquardt, Peter R. Galle, Arndt Vogel, Melanie Bathon, Tim Meyer, Ismaïl Labgaa, Antonia Digklia, Lewis R. Roberts, Mohamed A. Mohamed Ali, Beatriz Mínguez, Davide Citterio, Vincenzo Mazzaferro, Fabian Finkelmeier, Jörg Trojan, Burcin Özdirik, Tobias Müller, Moritz Schmelzle, Anthony Bejjani, Max W. Sung, Myron Schwartz, Richard S. Finn, Swan N. Thung, Augusto Villanueva, Daniela Sia, Josep M. Llovet
Topics & Concepts
Hepatocellular carcinomaMedicineImmunotherapyOncologyImmune checkpointCancer researchImmune systemTranscriptomeHCCSInternal medicineCancerImmunologyGeneGene expressionBiologyGeneticsHepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and BiomarkersCholangiocarcinoma and Gallbladder Cancer Studies